Close
Nordic 9Nordic 9

Hyloris Pharmaceuticals (investor - Corporate Investor)

Belgium hyloris.com
See something wrong or missing? Let us know
Offices:Liege
Average round investment:17.21M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Netherlands Pleco Therapeutics
Mostly invests in: Netherlands Netherlands (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Hyloris Pharmaceuticals

Name Criteria
Netherlands Netherlands Enterprise Agency
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Wellington Partners
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Netherlands Thuja Capital Management B.V.
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Belgium Gemma Frisius Fund
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany 2invest
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Alef 6
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Ace Ventures
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Finland Ilmarinen
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Sweden Novax
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Italy Ersel
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top